there is a small completed falling wedge pattern that has been broken and tested.Cnsp is ready to jump to close 4.6 gap . I am not advising you to buy or sell. this is what I have seen and i would like to share it to get a proper technical discussion.
This is not a financial advice! Most info on the chart. Trade carefully!
Which is a technical confirmation of an impulse in the direction preceding the crossing, invalidated by the crossing of the said level once in the opposite direction. Don't worry if that doesn't make any sense to you. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are...
Chart's pattern and its resistance at around current price make a sharp price change foreseeable. Recommended for Midterm.
Disclaimer Standard disclaimer, not financial advisor, nor a wizard of the stonks. This is a basic chart analysis, CNSP had a solid catalyst previously that yielded nothing, meaning there is gas in the tank for any ride up. Either way, sitting nicely around bottom resistance band, which could be good, or if it dips below, it could signal a drastic investor shift...
Possible Elliot Wave formation, next catalyst could be the fifth point of the impulse! Fundamentals are golden: Institutional ownership has increased over last period, with no sells. Float is ~15 million shares, short% is 3.45, Beta is 2.54, NASDAQ year end estimate is >8$/share. CNSP is a clinical stage biotech that deals with Central Nervous System cancers,...
Long CNSP to $4.12 above 3.50 CNSP has reentered a trading range if you look left. Symmetrical triangle formation, in confluence with the 786 fib, and monthly resistance levels. 100% measured move on the possible breakout would put us near $4.20, and just under a historical closing range at $4.32 Possible targets above that would be the 1.618 fib at 4.66, or...
“Strong Buy” Penny Stock With Over 200% Upside on the Horizon a biotechnology company with a focus on the treatment of glioblastomas, a class of aggressive tumors that attack the braid and spinal cord. These cancers, while rare, are almost always terminal, and CNS is working a new therapy designed to more effectively cross the blood-brain barrier to attack...
No Investment Advise! Most information on the Chart I do this only for practicing. We might see 1.20 (all time Low) before we reverse. Keep in mind there was an Offering at 2.00
Break out. Yes there is plenty of risk on this one. But looks really good for a small position, with potential for a big reward.